BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16920751)

  • 1. Need for improved outcome measures in pulmonary arterial hypertension related to systemic sclerosis.
    Distler O; Behrens F; Huscher D; Foeldvari I; Zink A; Nash P; Denton CP; Humbert M; Matucci-Cerinic M; Seibold J; Rubin L; Furst DE
    Rheumatology (Oxford); 2006 Dec; 45(12):1455-7. PubMed ID: 16920751
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pulmonary arterial hypertension in collagen disease: findings of the German Network for Systemic Scleroderma].
    Halank M; Seyfarth HJ; Opitz C; Schmeisser A; Ewert R; Höffken G
    Dtsch Med Wochenschr; 2007 Feb; 132(7):337; author reply 338. PubMed ID: 17286224
    [No Abstract]   [Full Text] [Related]  

  • 3. Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysis.
    Distler O; Behrens F; Pittrow D; Huscher D; Denton CP; Foeldvari I; Humbert M; Matucci-Cerinic M; Nash P; Opitz CF; Rubin LJ; Seibold JR; Furst DE;
    Arthritis Rheum; 2008 Jun; 59(6):867-75. PubMed ID: 18512721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism.
    Hachulla E; Coghlan JG
    Ann Rheum Dis; 2004 Sep; 63(9):1009-14. PubMed ID: 15308510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary arterial hypertension: are we doing enough to identify systemic sclerosis patients at high risk of this rare condition?
    Black C
    Rheumatology (Oxford); 2005 Feb; 44(2):141-2. PubMed ID: 15681336
    [No Abstract]   [Full Text] [Related]  

  • 6. Ivabradine in systemic sclerosis related pulmonary arterial hypertension.
    Correale M; Montrone D; Ieva R; Di Biase M; Brunetti ND
    Eur J Intern Med; 2012 Dec; 23(8):e210-1. PubMed ID: 23021874
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pulmonary arterial hypertension in connective tissue disease].
    Cottin V
    Rev Mal Respir; 2006 Sep; 23(4 Suppl):13S61-72. PubMed ID: 17057632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary hypertension in systemic sclerosis: bete noire no more?
    Varga J
    Curr Opin Rheumatol; 2002 Nov; 14(6):666-70. PubMed ID: 12410089
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcome measures in pulmonary arterial hypertension associated with systemic sclerosis.
    Kowal-Bielecka O; Delcroix M; Vonk-Noordegraaf A; Hoeper MM; Naeije R
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v39-41. PubMed ID: 18784140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ambrisentan on digital ulcers in systemic sclerosis: a case report.
    Tomaselli V; D'Ambrosio D; Massarelli L; Roccatello D
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-230-1. PubMed ID: 24774305
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of pulmonary arterial hypertension due to scleroderma: challenges for the future.
    Rubin LJ
    Rheum Dis Clin North Am; 2008 Feb; 34(1):191-7; viii. PubMed ID: 18329540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epoprostenol for pulmonary hypertension in scleroderma.
    Klings ES; Farber HW
    Ann Intern Med; 2000 Jul; 133(2):158. PubMed ID: 10896643
    [No Abstract]   [Full Text] [Related]  

  • 13. Pulmonary arterial hypertension in systemic sclerosis: can we predict responders for successful therapy?
    Sasahara AA
    J Rheumatol; 2009 Apr; 36(4):665-6. PubMed ID: 19342719
    [No Abstract]   [Full Text] [Related]  

  • 14. Transient effect of nifedipine on pulmonary hypertension of systemic sclerosis.
    Fudman EJ; Kelling DG
    J Rheumatol; 1985 Dec; 12(6):1191-2. PubMed ID: 4093929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and therapy of pulmonary hypertension in systemic sclerosis.
    Bull TM
    Curr Opin Rheumatol; 2007 Nov; 19(6):598-603. PubMed ID: 17917541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary arterial hypertension in systemic sclerosis: diagnostic pathway and therapeutic approach.
    Robertson L; Pignone A; Kowal-Bielecka O; Fiori G; Denton CP; Matucci-Cerinic M
    Ann Rheum Dis; 2005 Jun; 64(6):804-7. PubMed ID: 15897302
    [No Abstract]   [Full Text] [Related]  

  • 17. N-terminal pro-brain natriuretic peptide in systemic sclerosis related pulmonary arterial hypertension under bosentan treatment.
    Dimitroulas T; Giannakoulas G; Karvounis H; Dimitroula H; Settas L
    Rheumatol Int; 2009 Jan; 29(3):347-8. PubMed ID: 18690444
    [No Abstract]   [Full Text] [Related]  

  • 18. Palliation of systemic sclerosis-associated pulmonary hypertension by atrial septostomy.
    Allcock RJ; O'Sullivan JJ; Corris PA
    Arthritis Rheum; 2001 Jul; 44(7):1660-2. PubMed ID: 11465717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pulmonary arterial hypertension as symptom of a limited form of systemic sclerosis in a nonagenerian].
    Fernández Ibáñez JM; Morales Ballesteros C; Carrasco Fernández JA; Perez Alonso L
    Rev Esp Geriatr Gerontol; 2010; 45(6):361-2. PubMed ID: 20678826
    [No Abstract]   [Full Text] [Related]  

  • 20. Epoprostenol (prostacyclin) and pulmonary hypertension.
    Fishman AP
    Ann Intern Med; 2000 Mar; 132(6):500-2. PubMed ID: 10733452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.